Literature DB >> 26238426

Peroxisome proliferator-activated receptor γ prevents the production of NOD-like receptor family, pyrin domain containing 3 inflammasome and interleukin 1β in HK-2 renal tubular epithelial cells stimulated by monosodium urate crystals.

Wei Hong1, Shasha Hu2, Jianan Zou2, Jing Xiao2, Xiaoli Zhang2, Chensheng Fu2, Xinhui Feng2, Zhibin Ye2.   

Abstract

Recent evidence showed that peroxisome proliferator‑activated receptor γ (PPARγ) ameliorates a variety of inflammatory conditions. The present study aimed to investigate the role of PPARγ in regulating NOD-like receptor family, pyrin domain containing 3 (NALP3) inflammasome and interleukin (IL)‑1β levels during monosodium urate (MSU) crystal‑induced inflammation. HK‑2 cells were incubated with or without 200 µg/ml MSU crystals, and mRNA and protein levels of PPARγ were determined using reverse transcription quantitative polymerase chain reaction and western blot analysis, respectively. To verify the role of PPARγ, HK‑2 cells were pre‑treated with PPARγ agonist pioglitazone, and the levels of NALP3 inflammasome and IL‑1β were detected by western blot analysis and ELISA. The results showed that MSU crystals increased PPARγ expression in HK‑2 cells at 24 h, while the expression decreased to normal levels at 48 h. It was also demonstrated that although the PPARγ agonist pioglitazone did not alter the mRNA and protein levels of PPARγ, it significantly reduced the MSU crystal‑induced production of NALP3 inflammasome and IL‑1β in HK‑2 cells, possibly by increasing the level of PPARγ activity. In conclusion, the results of the present study indicated that PPARγ prevented NALP3 inflammasome formation and IL‑1β production in HK‑2 cells stimulated by MSU crystals, which indicated that PPARγ may represent a novel target for the treatment of hyperuricemic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26238426     DOI: 10.3892/mmr.2015.4145

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

1.  Therapeutically Targeting the Inflammasome Product in a Chimeric Model of Endometriosis-Related Surgical Adhesions.

Authors:  Meredith M Stocks; Marta A Crispens; Tianbing Ding; Shilpa Mokshagundam; Kaylon L Bruner-Tran; Kevin G Osteen
Journal:  Reprod Sci       Date:  2017-03-21       Impact factor: 3.060

2.  Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.

Authors:  Yao Wang; Bo Yu; Li Wang; Ming Yang; Zhiyin Xia; Wei Wei; Fengyu Zhang; Xiaochen Yuan
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

3.  Protective Effect of Artemisia argyi and Its Flavonoid Constituents against Contrast-Induced Cytotoxicity by Iodixanol in LLC-PK1 Cells.

Authors:  Dahae Lee; Chang-Eop Kim; Sa-Yoon Park; Kem Ok Kim; Nguyen Tuan Hiep; Dongho Lee; Hyuk-Jai Jang; Jae Wook Lee; Ki Sung Kang
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

4.  Propofol ameliorates endotoxin‑induced myocardial cell injury by inhibiting inflammation and apoptosis via the PPARγ/HMGB1/NLRP3 axis.

Authors:  Hui Zhao; Ying Gu; Hai Chen
Journal:  Mol Med Rep       Date:  2021-01-05       Impact factor: 2.952

Review 5.  Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway.

Authors:  Hélène Duez; Benoit Pourcet
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

Review 6.  Aging and Renal Disease: Old Questions for New Challenges.

Authors:  Yu-Hsiang Chou; Yung-Ming Chen
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

Review 7.  Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function.

Authors:  Ahmad Alatshan; Szilvia Benkő
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

8.  Inhibitory effect of PPARγ on NLRP3 inflammasome activation.

Authors:  Ching-Chun Yang; Chih-Hsing Wu; Ta-Chun Lin; Yi-Ning Cheng; Chin-Sung Chang; Kuo-Ting Lee; Pei-Jane Tsai; Yau-Sheng Tsai
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

9.  Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-β1/Smad3 Signaling Pathway in Hyperuricemic Nephrology Rats.

Authors:  Peng Liu; Chen Wang; Yun Wang; Honghong Zhang; Baoli Liu; Xinping Qiu
Journal:  Biomed Res Int       Date:  2021-12-13       Impact factor: 3.411

10.  Asiatic acid protects against hepatic ischemia/reperfusion injury by inactivation of Kupffer cells via PPARγ/NLRP3 inflammasome signaling pathway.

Authors:  Ying Xu; Jun Yao; Chen Zou; Heng Zhang; Shouliang Zhang; Jun Liu; Gui Ma; Pengcheng Jiang; Wenbo Zhang
Journal:  Oncotarget       Date:  2017-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.